Flinn Foundation

The Flinn Foundation operates as one of Arizona's most strategically focused philanthropies, with a clear internal roadmap that governs nearly every grantmaking decision. Understanding this means recognizing that the foundation is not a traditional open-grant funder — it rarely responds to unsolicited proposals. Instead, it invites applications from organizations whose work advances specific, pre-identified priorities outlined in Arizona's Bioscience Roadmap (now in its third iteration, released September 2025) and its internal program plans for civic leadership, arts, and education.

The foundation's four program pillars are unequal in openness. Bioscience is the flagship — consuming the largest share of staff attention and grantmaking — and it runs two structured, competitive programs (Seed Grants and the Entrepreneurship Program) with defined cycles. Flinn Scholars is an internal scholarship program with no direct grant path for nonprofits. Civic Leadership (the Flinn-Brown Fellowship and CivEx) primarily operates as a foundation-run initiative rather than an external grantmaking program. Arts and Culture has historically funded Arizona's largest cultural institutions through multi-year grants, but this program is more selective and appears to operate largely through ongoing relationships rather than open competitions.

First-time applicants in bioscience should prioritize attending the Bio Capital Conference (annual, March, in Phoenix) — this is the single highest-value touchpoint with Flinn staff and the broader bioscience ecosystem the foundation stewards. Conversations here precede successful grant applications. For arts organizations, demonstrating a track record with the Arizona Commission on the Arts or SMU DataArts (both Flinn grantees) can establish credibility. The foundation's top 10 grantees by total dollars are almost exclusively Arizona public research universities and their affiliated entities — ASU ($6M+), UA ($3.3M+), UArizona College of Pharmacy ($1.4M), and Northern Arizona University ($1.1M) — making institutional affiliation a meaningful advantage in bioscience programs. Independent organizations without university partnerships receive smaller, targeted grants, typically in the $100,000-$500,000 range for specific ecosystem-support activities.

The Flinn Foundation's grantmaking shows consistent scale and clear program segmentation across fiscal years. Total giving has risen from $10.5M (FY2015) to $13.4M (FY2023), with assets growing from $204M to $263M over the same period. The 5% payout rule implies a theoretical giving capacity of ~$13M annually at current asset levels, which matches observed behavior.

Bioscience Seed Grants: The primary competitive program awards exactly 10 grants of $100,000 each per cycle ($1M total/year). Top performers receive a follow-on grant of an additional $100,000, bringing potential total to $200,000 over ~30 months. The application success rate runs 12-14%. Over the reviewed grantee history, ASU and UA collectively received $9.3M of the foundation's $31.6M in tracked grants — roughly 29% of all recorded giving concentrated in two institutions.

Bioscience Other Grants: Bridge Funding Initiative grants (supporting researchers between federal grant cycles) and Translational Research Grants appear in the $100,000-$665,000 range, typically awarded to established research teams at Arizona universities and affiliated medical schools. UA College of Medicine Phoenix received $5.7M across 9 grants — among the largest single-recipient relationships outside of ASU main campus.

Arts and Culture: Historical grants to institutions like Ballet Arizona, Phoenix Art Museum, Childsplay, and Museum of Northern Arizona ranged from $140,000-$301,000 per organization, typically structured as multi-year awards. The COVID recovery rounds (2020-2022) temporarily increased volume; the current program focuses on longer-term capitalization rather than operating support.

Average and Median: The foundation's own data shows a median grant of $25,000 (driven by smaller scholarship-related disbursements) and an average of $79,259 across 71 tracked grants. The typical competitive research grant runs $100,000-$200,000. Larger ecosystem grants (bioscience infrastructure, economic analysis) can reach $495,000-$665,000. The largest single grant in the grantee record was $665,757 to ASU Foundation for a Medical Engineering division.

The Flinn Foundation sits among mid-sized private foundations with assets in the $250-275M range, most peer foundations in the Granted database focus on education broadly. Flinn is highly distinctive in its place-based, sectoral focus on Arizona bioscience.

Flinn stands apart from its asset peers in several key ways. Unlike Ruth Mott (which focuses on a single post-industrial city) or Making Waves (which runs its own programs), Flinn operates as both a grantmaker and a convener and ecosystem builder — actively managing Arizona's Bioscience Roadmap, running the Bio Capital Conference, and staffing civic leadership programs in-house. This dual role means that even when your organization is not a grant recipient, participating in Flinn-convened activities builds the relationship capital that makes future grants possible. The foundation's peer set nationally is better described as regional science foundations like the Whitaker Foundation or state bioscience initiative funds than typical education funders of comparable asset size.

The Flinn Foundation entered 2025-2026 with a full program calendar and visible public momentum. In January 2025, the foundation announced 10 Seed Grant recipients — three from ASU, seven from UA — each receiving $100,000 for translational research. The Bio Capital Conference returned March 5, 2026 at Creighton University Health Sciences Campus at Park Central (Midtown Phoenix), serving as the annual showcase for bioscience ecosystem activity and the venue where the next Seed Grant cohort will be revealed.

A significant milestone arrived in September 2025: the release of the third iteration of Arizona's Bioscience Roadmap, which the Flinn Foundation has stewarded since the original 2002 version. This updated strategic framework will shape bioscience grantmaking priorities through at least 2030 and represents the clearest signal of where the foundation intends to direct resources.

On the civic leadership front, 2026 marks the 15th anniversary of the Arizona Center for Civic Leadership, home of the Flinn-Brown Fellowship. The 2025 Flinn-Brown Convention was held August 15, 2025 at On Jackson in Phoenix.

The foundation also mourned the loss of John W. Murphy, its founding president and CEO, who died in 2025 at age 88. Murphy was credited with transforming Arizona philanthropy during his tenure. Current leadership — President & CEO Tammy McLeod (compensation $439,046) and CFO Stacy Tucker ($235,700) — continues to lead the organization through this institutional transition. Board Chairman David J. Gullen, M.D., and Secretary Eric Reiman, M.D. (2025 AZBio Pioneer Award recipient) anchor strong medical-scientific governance.

Know the program before you approach. The foundation runs discrete programs with defined cycles — not a rolling open-grant process. Identify whether your project aligns with the Translational Seed Grants (research teams at Arizona universities), the Bioscience Entrepreneurship Program (early-stage AZ companies), or an arts/culture initiative. Mismatched applications are rejected without feedback.

The Bio Capital Conference is your best first move. Attending the annual March conference in Phoenix gives you direct access to Flinn program officers in an environment where relationship-building is expected. Introduce yourself, understand their current priorities, and ask whether your work aligns before investing in a full proposal.

Translate rigorously. For Seed Grants, the selection criterion is explicit: projects must address 'a well-defined and compelling clinical need' with a plausible translational pathway. Frame your proposal around the patient or clinical outcome first, then the science. Pure basic research without an identified clinical application is noncompetitive. Include a clear development milestone that demonstrates feasibility within the 18-month grant period.

Budget for the 10% indirect cost cap. This is a hard limit — indirect costs above 10% of direct costs are not reimbursable. Plan your budget with this constraint from the start. Over-engineering the indirect budget has disqualified otherwise strong proposals.

Demonstrate Arizona-rootedness. The foundation's entire mandate is to build Arizona's bioscience infrastructure. Proposals that explicitly frame outcomes in terms of Arizona workforce, Arizona clinical delivery, or Arizona economic development score higher than those treating Arizona as incidental geography.

For arts applicants: Your organization must have a minimum annual budget of $2.5M and be located in Phoenix, Tucson, or Flagstaff metro areas. Demonstrating data-driven financial management — particularly participation in SMU DataArts (a Flinn-supported tool) — signals alignment with the foundation's emphasis on organizational health and transparency.

Follow-on strategy: Design your Seed Grant deliverables with a sequel in mind. The foundation awards follow-on grants of $100,000 to top performers. Applicants who structure their initial 18-month scope to produce a clear, compelling next step are better positioned for continuation funding.